“Only 50% of Chinese vaccine effectiveness”… Proliferation of opinions against purchase in the Philippines

COVID-19 vaccine produced by Sinobac-SCMP capture

In the Philippines, which announced plans to purchase a vaccine for a novel coronavirus infection (Corona 19) developed by a Chinese pharmaceutical company Sinobac, voices are rising against the purchase.

On the 25th (local time), according to local media in the Philippines, including Raffler, members of the ruling and opposition lawmakers expressed their opposition to the government’s plan to purchase a synovac vaccine. Senate leader Juan Zubiri and opposition leader Franklin both issued opposition statements.

They were based on a Brazilian study that found that the synovac vaccine had only 50% of the corona 19 prevention effect.

Earlier, on the 23rd, the Butantang Research Center under the government of Sao Paulo, Brazil, analyzed data from a phase 3 clinical trial of the Synovac vaccine, and revealed that it showed more than 50% of the preventive effect.

The Butantang Research Institute did not disclose accurate clinical trial data.

The result of this analysis is that female and night lawmakers in the Philippines oppose the purchase of vaccines. Congressman Jubi-ri criticized that “the plan to secure a vaccine with only 50% preventive effect is unacceptable,” and “it is funny that the possibility of getting the corona 19 virus after vaccination is 50-50.”

Rep. Drillon also said, “It is important to supply the vaccine as soon as possible, but safety and efficacy should be prioritized over anything else,” and “I doubt how to build public trust with a 50% effective vaccine.” Loaded.

Earlier, the Philippines announced plans to purchase 25 million doses of vaccine from China’s Sinovac by March next year. The Philippine government is not only in contact with Sinobag, but also with several pharmaceutical companies such as Pfizer and Moderna and AstraZeneca.

However, voices against the Philippine government’s purchase of a sinovac vaccine have erupted, raising concerns that the government’s purchase plan may be disrupted.

[email protected]